What is it about?
When to treat smoldering multiple myeloma is controversial. Some randomized controlled trials (RCTs) have been conducted, but they used different treatment and had different results. This paper conducts a meta-analysis of these RCTs, and examines the optimal timing and therapy to treat smoldering multiple myeloma, especially high-risk patients.
Photo by roya ann miller on Unsplash
Why is it important?
Smoldering multiple myeloma can progress to symptomatic multiple myeloma and can be lethal. But when to treat smoldering multiple myeloma has been controversial. Finding out when and how to manage smoldering multiple myeloma is important.
Read the Original
This page is a summary of: Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies, Cancer Management and Research, June 2019, Dove Medical Press, DOI: 10.2147/cmar.s205623.
You can read the full text:
The following have contributed to this page